Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival

Ya Chi Huang, Sue Jane Lin, Kai Min Lin, Ya Ching Chou, Chung Wu Lin, Shan Chi Yu, Chi Long Chen, Tang Long Shen, Chi Kuan Chen, Jean Lu, Mei Ru Chen, Ching Hwa Tsai

研究成果: 雜誌貢獻文章

7 引文 斯高帕斯(Scopus)

摘要

Epstein-Barr virus (EBV), an oncogenic human virus, is associated with several lymphoproliferative disorders, including Burkitt lymphoma, Hodgkin disease, diffuse large B-cell lymphoma (DLBCL), and posttransplant lymphoproliferative disorder (PTLD). In vitro, EBV transforms primary B cells into lymphoblastoid cell lines (LCLs). Recently, several studies have shown that receptor tyrosine kinases (RTKs) play important roles in EBV-associated neoplasia. However, details of the involvement of RTKs in EBV-regulated B-cell neoplasia and malignancies remain largely unclear. Here, we found that erythropoietinproducing hepatocellular receptor A4 (EphA4), which belongs to the largest RTK Eph family, was downregulated in primary B cells post-EBV infection at the transcriptional and translational levels. Overexpression and knockdown experiments confirmed that EBV-encoded latent membrane protein 1 (LMP1) was responsible for this EphA4 suppression. Mechanistically, LMP1 triggered the extracellular signal-regulated kinase (ERK) pathway and promoted Sp1 to suppress EphA4 promoter activity. Functionally, overexpression of EphA4 prevented LCLs from proliferation. Pathologically, the expression of EphA4 was detected in EBV- tonsils but not in EBV+ PTLD. In addition, an inverse correlation of EphA4 expression and EBV presence was verified by immunochemical staining of EBV+ and EBV- DLBCL, suggesting EBV infection was associated with reduced EphA4 expression. Analysis of a public data set showed that lower EphA4 expression was correlated with a poor survival rate of DLBCL patients. Our findings provide a novel mechanism by which EphA4 can be regulated by an oncogenic LMP1 protein and explore its possible function in B cells. The results provide new insights into the role of EphA4 in EBV+ PTLD and DLBCL.
原文英語
頁(從 - 到)1578-1589
頁數12
期刊Blood
128
發行號12
DOIs
出版狀態已發佈 - 2016
對外發佈Yes

ASJC Scopus subject areas

  • Immunology
  • Biochemistry
  • Hematology
  • Cell Biology

指紋 深入研究「Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival」主題。共同形成了獨特的指紋。

  • 引用此

    Huang, Y. C., Lin, S. J., Lin, K. M., Chou, Y. C., Lin, C. W., Yu, S. C., Chen, C. L., Shen, T. L., Chen, C. K., Lu, J., Chen, M. R., & Tsai, C. H. (2016). Regulation of EBV LMP1-triggered EphA4 downregulation in EBV-associated B lymphoma and its impact on patients' survival. Blood, 128(12), 1578-1589. https://doi.org/10.1182/blood-2016-02-702530